The document explains how Quantiphi delivers domain-specific generative AI solutions to modernize the pharma value chain while addressing common AI challenges such as clinical risks, bias, privacy concerns, and lack of biomedical training. Page 1 outlines targeted use cases across drug discovery, R&D knowledge synthesis, clinical trials, post-marketing intelligence, and sales and marketing. Page 2 describes the Quantiphi advantage, powered by BioNeMo and NeMo frameworks, enabling secure deployment, PHI de-identification, domain adaptation, bias correction, and continuous learning. Benefits include faster drug discovery, optimized trials, 25% productivity gains, and improved employee efficiency with LLM-powered tools.

Join for free to read